Carregant...
The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study
AIM: To compare the early biochemical response and rate of adverse effects in patients who received prednisolone (PRED)/azathioprine (AZA) and those who received budesonide (BUD)/AZA as the first-line treatment for autoimmune hepatitis. METHODS: The study involved 25 patients receiving PRED 30 mg/da...
Guardat en:
| Publicat a: | Croat Med J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Croatian Medical Schools
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734566/ https://ncbi.nlm.nih.gov/pubmed/31483120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2019.60.345 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|